Jan 29, 2019 - Array BioPharma (ARRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Feb 05, 2019 - The following slide deck was published by Array BioPharma Inc. in conjunction with their 2019 Q2 earnings call.
Feb 05, 2019 - ARRY earnings call for the period ending December 31, 2018.
Feb 06, 2019 -
Dec 11, 2018 - Moderna is a speculative buy.Trading volume is like a polygraph for stocks.Healthcare sector is recession proof.
Jan 02, 2019 - CommScope (COMM +3%) has refiled for Hart-Scott-Rodino clearance of its deal to buy Arris (ARRS -0.8%), Bloomberg reports. Arris has trimmed some of the day's losses amid that news. Shares were down
Jan 07, 2019 - Shares of all three cancer-focused companies shot higher after one of their peers got bought out for a sizable premium.
Jan 29, 2019 - Is (ARRY) Outperforming Other Medical Stocks This Year?
Feb 05, 2019 - Array BioPharma (ARRY) delivered earnings and revenue surprises of 68.75% and 68.41%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Feb 05, 2019 - Array Biopharma, Inc. (NASDAQ:ARRY) Q2 2019 Earnings Conference Call February 05, 2019, 09:00 ET Company Participants Andrea Flynn - Senior Director, IR & Corporate Communications Ron Squarer - CE